France: Alpera Partners announces launch as independent investment company
France-based Alpera Partners, previously operating under the name Otium Partners is adopting its own identity as an independent investment company owned by its managers...
France: PAI said to be readying sale of Ethypharm
Media reports point to PAI Partners selling Ethypharm, a France-based pharmaceutical company with a focus on hospital injectables, pain and addiction treatment, for more than...
UK: LDC-backed Agentis Health Group launches with first acquisition
Agentis Health Group, a UK-based digital health management specialist, has officially launched following the acquisition of Living With, a digital health company specialising in...
Germany: Vivecti and Sana join forces to create leading European tech-driven procurement network
The Vivecti Group, a portfolio company of Nordic Capital, and Sana Kliniken are entering into a strategic partnership whereby Vivecti is taking over the...
Switzerland: Roche to acquire 89bio in deal of up to US$3.5bn
Switzerland-headquartered Roche, the world’s largest biotech company and the global leader in in-vitro diagnostics, is acquiring Nasdaq-listed 89bio, a clinical-stage biopharmaceutical company pioneering the...
Georgia: IFC anchors Georgia Healthcare Group’s GEL350m social bond
IFC is anchoring a Georgian lari GEL350m (approximately US$130m) social bond issuance by Georgia Healthcare Group, the country’s largest healthcare services provider, through a...
France: Keensight Capital acquires majority stake in Isto Biologics from Thompson Street Capital Partners
Keensight Capital, a France-based private equity manager dedicated to pan-European Growth Buyout investments, has agreed to acquire a majority stake in US-based Isto Biologics from...
The Netherlands: CSL partners with VarmX on first-in class coagulation treatment
ASX-listed CSL, a global biotechnology company, has entered into an agreement with Netherlands-based biotech company, VarmX, to develop a new treatment to restore blood...
Australia: Demetra adds to portfolio of infection management solutions with Next Science asset purchase
Demetra, an independent international medical company providing bone cements, spacers and biomaterials for orthopaedic applications and orthopaedic infection control, has announced a strategic asset purchase...
France: Verto announces final close of Verto Growth II and team additions
France-based Verto, an independent growth equity firm, has announced the final close of Verto Growth II at its revised hard cap of €330m (US$390m),...
Advertisement
